A shadow market for unapproved slimming drugs is being driven by social media fitness personalities and sellers on communication apps, based on new investigations.
Investigational Drug Acquiring Popularity Via Social Media
Retatrutide, which remains in research studies, is being promoted by online personalities for its alleged fat-burning properties. Viewers are encouraged to message these accounts privately for source information, while also receiving discount codes.
Active Commerce on Messaging Platforms
Separately, a robust market exists on messaging services, where groups with thousands of members share “before and after” photos, injection guides and claims of rapid British shipping. Sellers market the drug there before redirecting buyers to other platforms for purchases.
Learning About Retatrutide
This medication is an experimental injection created by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies suggest it could help individuals lose up to 25% of their total weight. Nicknamed the “triple G”, the substance is being hailed online as the next Ozempic.
Healthcare Professionals Express Worries
However, doctors and chemists have warned that the distribution of what remains an unlicensed drug in the UK is a cause for concern and could result in individuals injecting substances of unknown origin.
Several professionals stated the demand for the experimental drug could be connected to the increasing price of licensed weight loss products such as Mounjaro.
Regulatory Position and Implementation
Selling the unapproved drug on social media or Telegram is illegal in the United Kingdom, as it is an unlicensed medication that must not be marketed or supplied for personal consumption under the British medical regulations.
Several influencers attempt to circumvent the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and supply can still violate pharmaceutical, marketing, and customer laws, risking penalties, prosecution or imprisonment.
Service Reaction and Material Elimination
Based on TikTok, the service has taken down violative content and banned related hashtags and query recommendations. The company said it was dedicated to keeping the platform safe and investing in enhancing compliance measures.
Online Marketplace Operations
Research also found communities with up to 9,000 participants marketing the experimental drug using the platform's built-in discovery tool, which functions like a public directory. Entering “retatrutide” instantly displays channels with thousands of users, filled with images of slimming results, glowing testimonials and step-by-step instructions for preparing or injecting at residence.
Within minutes of joining one group, a vendor posted contact information, where most purchases take place. The seller provided an guidebook and guaranteed shipping within two days. When questioned whether the substance was authentic, one seller said: “You can’t be sure.” Another shared a photo of a supposed testing documentation. None asked about body mass, medical conditions or previous experience.
Product Information and Pricing
Within these communities, posts display black plastic parcels with Royal Mail stickers, claiming to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, mixed at home with sterile water, or pre-filled injectors typically sold at £160 for 20 milligrams. When asked how much time a injector should last, vendors give contradictory answers ranging from a several days to “depends on your body”.
Service Moderation and Safety Measures
A representative for Telegram stated it actively monitored harmful content on its platform including content that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Medical Expert Warnings
“Individuals are administering materials they can’t verify. Even if the science behind this drug is valid, these digital versions may not include what they claim,” stated a pharmacy expert, the head of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of an online medical service connected the surge in demand to recent cost increases for approved weight-loss drugs such as Mounjaro. “With costs increasing, individuals are turning to online platforms. But counterfeit injections are extremely dangerous. You cannot know what’s inside or whether the conditions they were made in was sterile,” she explained.
Her team has already seen patients harmed by personal administration from unconfirmed sources. “We recognize the disappointment, but purchasing from messaging apps or communication platforms is gambling with your health,” said Wyllie. “These substances could be impure or incorrectly dosed.”
Producer Statement
A representative from the pharmaceutical company said retatrutide was in phase 3 clinical trials and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Therefore at this time no one can sell [it] for personal consumption,” they said, noting that any item “falsely representing itself as a Lilly experimental substance not yet authorized … may expose users to possibly serious medical dangers”.
